Canine treatment trial · November 9, 2026

Midwestern University lists a chemotherapy trial for dogs with five cancer diagnoses

Midwestern University in Glendale, Arizona, is inviting owners to ask about a chemotherapy study for dogs. The university lists five qualifying diagnoses: malignant melanoma, hemangiosarcoma, mammary cancer, soft tissue sarcoma and spindle cell carcinoma. The physical exam, bloodwork and chemotherapy provided through the study are free to owners of enrolled dogs.

Who may qualify

Dogs must be at least 12 months old and have a confirmed diagnosis. Prior corticosteroids, chemotherapy, immunotherapy or radiation exclude participation. The team also screens for other medical conditions that might affect treatment. Dogs cannot have a procedure under general anesthesia planned during the study.

What participation involves

Visits begin with an early morning drop-off, and dogs stay at the hospital for about five hours. The university’s listing does not name the chemotherapy drug, give the number of visits or publish an enrollment deadline.

Those details matter when one study includes several different cancers. Before planning a trip, ask what your dog would receive, how the team would measure response for that diagnosis, and whether any tests or care outside the study would be billed separately.

Study contacts: Dr. Kara Thomas and Dr. Natacha Montalvo.